Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe.

Shares of early-stage biotech stocks, including Biohaven ( BHVN -8.30%), Recursion Pharmaceuticals ( RXRX -3.98%), and CRISPR Therapeutics ( CRSP -1.49%), plunged in March, with the stocks down 35.3%, ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

Investors' deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approval and M&A Biotech is one of the U.S. stock market's most unloved sectors. But several ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce ...

Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.

A Verve Therapeutics treatment was found to cut cholesterol levels by more than half—with just one shot. The stock jumped ...

He said that looking at the denominator of biotech stocks in the public market, we’re standing at the 700-800 range, depending upon the day. Almost a quarter of these have enterprise values in ...

The market turbulence unleashed by President Donald Trump’s tariff policies will likely evaporate the trickle of biotech IPOs ...